| Name | 2-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2,3-dih ydro-1H-naphtho[1,8-de][1,3,2]diazaborinine | 
|---|---|
| Synonyms | 1-o-Methoxycarbonylphenyl-3-m-nitrophenyltriazen | 
| Molecular Formula | C22H24B2N2O2 | 
|---|---|
| Molecular Weight | 370.06000 | 
| Exact Mass | 370.20200 | 
| PSA | 42.52000 | 
| LogP | 3.64780 | 
| HS Code | 2934999090 | 
|---|
| ~77%   950511-17-8 | 
| Literature: Noguchi, Hiroyoshi; Shioda, Takayuki; Chou, Chih-Ming; Suginome, Michinori Organic Letters, 2008 , vol. 10, # 3 p. 377 - 380 | 
| ~61%   950511-17-8 | 
| Literature: Pfizer Limited; Omoto, Kiyoyuki; Owen, Robert McKenzie; Pryde, David Cameron; Watson, Christine Ann Louise; Takeuchi, Mifune Patent: US2014/171435 A1, 2014 ; Location in patent: Page/Page column ; | 
| ~%   950511-17-8 | 
| Literature: Pfizer Limited; Omoto, Kiyoyuki; Owen, Robert McKenzie; Pryde, David Cameron; Watson, Christine Ann Louise; Takeuchi, Mifune Patent: US2014/171435 A1, 2014 ; | 
| HS Code | 2934999090 | 
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |